President Trump's nominee for the Supreme Court, Neil Gorsuch, offers promise for the medtech space in legal areas of off-label communications and preemption, but there are some question marks.
The US Senate has scheduled confirmation hearings for Gorsuch to begin on March 20 with opening statements, followed by questioning...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?